NCT07633574

Brief Summary

This randomized controlled trial (RCT) compares the 24-month clinical performance of endocrown restorations fabricated by two digital manufacturing pathways: additive manufacturing using 3D-printed ceramic-filled photopolymer resin (VarseoSmile TriniQ, BEGO) versus subtractive computer-aided design/computer-aided manufacturing (CAD/CAM) milling from hybrid nano-ceramic blocks (HC Hard Block, Shofu). Sixty endocrowns will be placed in endodontically treated posterior molars and evaluated using modified United States Public Health Service (USPHS) criteria at 6, 12, and 24 months. The trial is conducted at the Conservative Dentistry Department, Faculty of Dentistry, Cairo University.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
25mo left

Started Jun 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jun 2026Sep 2028

First Submitted

Initial submission to the registry

May 30, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 8, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

June 8, 2026

Status Verified

June 1, 2026

Enrollment Period

2 years

First QC Date

May 30, 2026

Last Update Submit

June 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Restoration Fracture Resistance

    Assessed using modified USPHS criteria: Alpha = absence of fracture; Bravo = minor chip amenable to repair; Charlie = catastrophic fracture, unrestorable

    24 months

Secondary Outcomes (8)

  • Retention

    6, 12, and 24 months

  • Marginal Discoloration

    6, 12, and 24 months

  • Surface Texture

    6, 12, and 24 months

  • Anatomic Form

    6, 12, and 24 months

  • Color Match

    6, 12, and 24 months

  • +3 more secondary outcomes

Study Arms (2)

CAD/CAM Milled Endocrown

ACTIVE COMPARATOR

Endocrown restoration fabricated by subtractive CAD/CAM milling from HC Hard Block hybrid nano-ceramic (Shofu Inc., Japan), designed using ExoCAD software and milled on a five-axis wet-milling unit. Adhesively cemented using Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

Device: CAD/CAM Milled HC Hard Block Endocrown

3D-Printed Endocrown

EXPERIMENTAL

Endocrown restoration fabricated by additive manufacturing using VarseoSmile TriniQ ceramic-filled photopolymer resin (BEGO GmbH \& Co. KG, Germany), printed on a 4K LCD printer at 30-45 degree build angle, post-cured under nitrogen atmosphere. Adhesively cemented using Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

Device: 3D-Printed VarseoSmile TriniQ Endocrown

Interventions

Endocrown restoration milled from HC Hard Block hybrid nano-ceramic (Shofu Inc., Japan) using a five-axis wet-milling CAD/CAM unit. Restoration designed with ExoCAD software, finished and glazed per manufacturer protocol, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

Also known as: CAD/CAM Milled Endocrown
CAD/CAM Milled Endocrown

Endocrown restoration 3D-printed using VarseoSmile TriniQ ceramic-filled photopolymer resin (BEGO GmbH \& Co. KG, Germany) on a 4K LCD printer at 30-45 degree build angle. Post-cured under nitrogen atmosphere, surface glazed, and cemented with Beautilink SA self-adhesive dual-cure resin cement (Shofu Inc., Japan).

Also known as: 3D-Printed Endocrown
3D-Printed Endocrown

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 25-45 years, male or female
  • Endodontically treated molar tooth with radiographically confirmed treatment success and no clinical signs of failure
  • Sufficient remaining coronal structure for endocrown preparation: minimum three walls, wall thickness 1.5 mm or greater, pulp chamber depth 3 mm or greater, supragingival preparation margins
  • Completely erupted tooth with intact periodontal support
  • Minimum of 20 occluding teeth
  • Satisfactory oral hygiene status
  • Capable of providing written informed consent and committed to scheduled follow-up visits

You may not qualify if:

  • Diagnosed parafunctional habit or nocturnal bruxism
  • Uncontrolled systemic illness or physical disability precluding safe participation
  • Heavy tobacco use
  • Current or suspected pregnancy
  • Periapical disease or radiographic signs of endodontic failure
  • Evidence of pathological tooth wear or occlusal erosion
  • Moderate-to-severe periodontitis or tooth with hopeless prognosis
  • Radiographic or clinical evidence of vertical root fracture
  • Impaired decision-making capacity or anticipated non-compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Abou-Steit S, Ibrahim SH, Salem M. Three years clinical evaluation of lithium disilicate and hybrid nano-ceramic CAD/CAM endocrowns (randomized clinical trial). Egyptian Dental Journal 2024;70:551-561.

    BACKGROUND

MeSH Terms

Conditions

Tooth, Nonvital

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Central Study Contacts

Dina Ez Mohamed, BDS MSc PhD

CONTACT

Rawda H Abdelaziz, BDS MSc PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The treating clinician cannot be blinded due to visible differences between manufacturing workflows. Participants and outcome assessors are blinded to group allocation. The trial statistician is blinded to group assignment throughout analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Conservative Dentistry

Study Record Dates

First Submitted

May 30, 2026

First Posted

June 8, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

June 8, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share